Cano RMA, Gómez RN, Dorame CR, Contreras SJ, Talamante S

Language: Spanish
References: 12
Page: 142-146
PDF size: 109.80 Kb.

ABSTRACT

Background: Coccidioidomycosis was first described in the late 18^th century by Alejandro Posadas. The first case in Sonora was reported in 1948 by Madrid. Coccidioidomycosis is caused by both species of a dimorphic fungus, one limited to the California area (C.immitis) and the other a non-California strain (C. posadassi).
Clinical case: A 6-year-old male patient from Caborca, Sonora presented headache and projectile vomiting. At 2½ years of age he was treated at a hospital with the diagnosis of undetermined hydrocephalus. At 3½ years of age, a diagnosis of coccidioidal meningitis was made without knowing the serum antibody and cerebrospinal fluid (CSF) titers. He received treatment with fluconazole for 3 years with 1 month of amphotericin B deoxycholate. Upon admission to our hospital, elevated antibody CSF titers were present.
Conclusion: After being treated with liposomal amphotericin (2 mg/kg) for 9 months, he reached a total dose of 5475 mg, presenting good clinical outcome with decreased serum antibodies and CSF titers. During his treatment no clinical or laboratory data suggested toxicity due to liposomal amphotericin administration.

REFERENCES

1. Saubolle M, McKellar P, Sussland D. Epidemiological, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol 2007;46:26-30.

2. Einstein H, Johnson R. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 1993;16: 349-356.

3. Cano-Rangel M, Sotelo-Cruz N, Contreras-Soto J. Coccidioidomicosis diseminada con lesión cutánea tipo chancroide. Bol Med Hosp Infant Mex 2002;59:645-650.

4. DiCaudo D. Coccidioidomycosis: a review and update. J Am Acad Dermatol 2006;55:929-942.

5. Hector R, Laniado-Laborin R. Coccidioidomycosis¾a fungal disease of the Americas. PLoS Med 2005;2: 15-17.

6. Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002;94:73-84.

7. Johnson R, Einstein H. Coccidioidal meningitis. Clin Practice 2006;42:103-107.

8. Kafka JA, Catanzaro A. Disseminated coccidioidomycosis in children. J Pediatr 1981;98:355-361.

9. Clemons K, Sobel R, Williams O, Pappagianis D, Stevens D. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidoidal meningitis in rabbits. Antimicrob Agents Chemother 2002;46;2420-2426.

10. Papagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbol Rev 1990;3:247-268.

11. Goldman R, Koren G. Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol 2004;26:421-424.

12. Suresh A, Dominguez D, Sotelo E. Use of liposomal amphotericin B in treatment disseminated coccidioidomycosis. JNMA 2003;95:982-984.